Changing Tides? Anticancer Biologic and Biosimilar Use in Medicare Part B, 2019-2021
JCO oncology practice（2023）
摘要
Anticancer biosimilar use is rising but significant potential savings remain unrealized @alison_mcclean @ChrisLuPhD
更多查看译文
关键词
anticancer biologic,tides,biosimilar use
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要